Core Viewpoint - The company is currently in the early stages of launching new products, and their market performance is not expected to significantly impact this year's financial results [2]. Group 1: New Product Performance - The new products, including Tamsulosin and Minoxidil topical solution, are in the initial launch phase [2]. - The company anticipates that the impact of these new products on this year's performance will not be particularly significant [2]. Group 2: Business Strategy and Management - The company aims to continue focusing on its core business while enhancing operational management performance [2]. - Plans are in place to optimize corporate governance, strengthen core competitiveness, improve information disclosure, and enhance investor relations management [2]. - These strategies are intended to strengthen market value management and ensure that market value reflects the company's true worth, thereby protecting investor rights [2].
民生健康：公司酒石酸伐尼克兰片、米诺地尔搽剂等新品目前正处于上市初期阶段